Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Bone Biologics(BBLG) the EBIT is -808.11 K (-8.02%), Beat estimate;the EPS is -0.43 (+67.67%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.00B8.02%
-0.00B8.88%
+0.00B0.86%
EPSMiss expectations
-0.4367.67%
-0.3970.68%
-0.04003.01%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf